HLA-E polymorphisms in hematopoietic stem cell transplantation

被引：22
|
作者：
Fuerst, D. [1 ,2 ]
Bindja, J. [1 ,2 ]
Arnold, R. [3 ]
Herr, W. [4 ]
Schwerdtfeger, R. [5 ]
Mueller, C. H. [6 ,7 ]
Recker, K. [1 ,2 ]
Schrezenmeier, H. [1 ,2 ]
Mytilineos, J. [1 ,2 ,7 ]
机构：
[1] Baden Wuerttemberg Hessia, German Red Cross Blood Transfus Serv, Inst Clin Transfus Med & Immunogenet Ulm, Dept Transplantat Immunol, Ulm, Germany
[2] Univ Clin Ulm, Inst Transfus Med, Transplantat Immunol Lab, Ulm, Germany
[3] Charite Campus Virchow, Dept Hematol Oncol, Berlin, Germany
[4] Univ Clin Mainz, Dept Hematol Oncol, Mainz, Germany
[5] DKD Wiesbaden, Ctr Blood & Bone Marrow Transplantat, Wiesbaden, Germany
[6] ZKRD German Natl Bone Marrow Donor Registry, Ulm, Germany
[7] DRST German Registry Stem Cell Transplantat, Ulm, Germany
来源：
TISSUE ANTIGENS | 2012年 / 79卷 / 04期
关键词：
CD94; hematopoietic stem cell transplantation; HLA-E; HSCT; natural killer cell; NKG2A; PROPORTIONAL HAZARDS MODEL; BONE-MARROW; E BINDS; SUBDISTRIBUTION; ASSOCIATION; EXPRESSION; MORTALITY;
D O I：
10.1111/j.1399-0039.2011.01832.x
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Human leukocyte antigen (HLA)-E is an inhibitory ligand of natural killer cells and ?/d T-cells. Differential expression of HLA-E alleles on the cell surface has been reported to influence outcome of hematopoietic stem cell transplantation (HSCT). We performed HLA-E genotyping in 116 HSCT patients and their HLA-matched unrelated donors. The impact of HLA-E genotypes on patient's overall survival (OS), disease free survival (DFS), cumulative incidences for relapse, transplant-related mortality (TRM) and acute graft vs host disease (aGvHD) was assessed. Neither univariate nor multivariate analysis showed any influence of HLA-E polymorphisms on the investigated endpoints of HSCT in our cohort. We could not confirm any of the previous observations in our cohort and consider it unlikely that HLA-E polymorphisms affect outcome of HSCT.
引用
收藏
页码：287 / 290
页数：4
相关论文
共 50 条
  • [31] HLA-E
    许秀芳
    国外医学(免疫学分册), 2002, (05) : 234 - 237
  • [32] Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation
    Fernandez-Vina, Marcelo A.
    Wang, Tao
    Lee, Stephanie J.
    Haagenson, Michael
    Aljurf, Mahmoud
    Askar, Medhat
    Battiwalla, Minoo
    Baxter-Lowe, Lee-Ann
    Gajewski, James
    Jakubowski, Ann A.
    Marino, Susana
    Oudshoorn, Machteld
    Marsh, Steven G. E.
    Petersdorf, Effie W.
    Schultz, Kirk
    Turner, E. Victoria
    Waller, Edmund K.
    Woolfrey, Ann
    Umejiego, John
    Spellman, Stephen R.
    Setterholm, Michelle
    BLOOD, 2014, 123 (08) : 1270 - 1278
  • [33] Non-HLA immunogenetics in hematopoietic stem cell transplantation
    Dickinson, AM
    Charron, D
    CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (05) : 517 - 525
  • [34] Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells
    Siemaszko, Jagoda
    Lacina, Piotr
    Szymczak, Donata
    Szeremet, Agnieszka
    Majcherek, Maciej
    Czyz, Anna
    Sobczyk-Kruszelnicka, Malgorzata
    Fidyk, Wojciech
    Solarska, Iwona
    Nasilowska-Adamska, Barbara
    Skowronska, Patrycja
    Bieniaszewska, Maria
    Tomaszewska, Agnieszka
    Basak, Grzegorz W.
    Giebel, Sebastian
    Wrobel, Tomasz
    Bogunia-Kubik, Katarzyna
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] On the diversity of HLA-E: Identification of a novel HLA-E allele
    Forstmann, G
    Blasczyk, R
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : P367 - P367
  • [36] HLA-E GENE POLYMORPHISMS IN RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS
    Iwaszko, Milena
    Swierkot, Jerzy
    Sokolik, Renata
    Nowak, Beata
    Gebura, Katarzyna
    Korman, Lucyna
    Wiland, Piotr
    Bogunia-Kubik, Katarzyna
    TISSUE ANTIGENS, 2014, 84 (01): : 150 - 150
  • [37] Clinical significance of donor-recipient matching for non-classical HLA-E and HLA-G, and HSP70-HOM alleles for the outcome of hematopoietic stem cell transplantation
    Bogunia-Kubik, K.
    Jaskula, E.
    Gebura, K.
    Marzec, A.
    Iwaszko, M.
    Koscinska, K.
    Polak, M.
    Lange, A.
    TISSUE ANTIGENS, 2011, 77 (05): : 374 - 374
  • [38] HLA-E*0103 homozygosity: a protective factor against acute graft versus host disease and transplant related mortality after HLA-identical sibling hematopoietic stem cell transplantation
    Tamouza, R.
    Busson, M.
    Rocha, V.
    Socie, G.
    Krishnamoorthy, R.
    Toubert, A.
    Charron, D.
    TISSUE ANTIGENS, 2006, 67 (06): : 453 - 453
  • [39] Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation
    C-H Yan
    L-P Xu
    F-r Wang
    H Chen
    W Han
    Yu Wang
    J-z Wang
    K-Y Liu
    X-J Huang
    Bone Marrow Transplantation, 2016, 51 : 391 - 397
  • [40] Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation
    Yan, C-H
    Xu, L-P
    Wang, F-r
    Chen, H.
    Han, W.
    Wang, Yu
    Wang, J-z
    Liu, K-Y
    Huang, X-J
    BONE MARROW TRANSPLANTATION, 2016, 51 (03) : 391 - 397
12345